Meyka Pro banner
DEFIANCE KSM TIPRANKS ANALYST ETF

Stay Updated with the Latest DEFIANCE KSM TIPRANKS ANALYST ETF RANK News in Real Time

Find RANK news now at Meyka AI. Stay informed with the latest DEFIANCE KSM TIPRANKS ANALYST ETF stocks updates, including price news, market analysis, and expert insights.

RANKAMEX
Consumer CyclicalGambling, Resorts & Casinos
$18.92
$0.25(1.32%)
U.S. Market opens in 53h 12m
TGA Warns GLP-1 Drugs Linked to Rare Eye Blindness July 25
📅 4 hours ago

TGA Warns GLP-1 Drugs Linked to Rare Eye Blindness July 25

Australia’s TGA warns GLP-1 drugs like Ozempic and Mounjaro linked to 36 cases of NAION, a rare eye disorder causing permanent blindness. No treatment available.

Read more 12
Intel (NASDAQ: INTC) Stock Jumps 6% as Strong Forecasts Signal AI-Driven Turnaround
📅 15 hours ago

Intel (NASDAQ: INTC) Stock Jumps 6% as Strong Forecasts Signal AI-Driven Turnaround

Intel stock surged as much as 6% in after-hours trading Thursday, July 23, 2026. The jump followed second-quarter results that crushed Wall Street estimates. Revenue hit $16.1 billion, up 25% year-over-year, the fastest growth since 2011. Adjusted EPS came in at 42 cents versus the 21 cents analysts expected. Strong third-quarter guidance added further fuel…

Read more 12
discoverIE Group (LSE: DSCV) Shares Soar 12% as Strong Q1 Orders and Sales Beat Expectations
📅 16 hours ago

discoverIE Group (LSE: DSCV) Shares Soar 12% as Strong Q1 Orders and Sales Beat Expectations

discoverIE Group shares jumped 12% on Friday, July 24, 2026, after a strong Q1 trading update. Group orders rose 31% organically, while sales climbed 6% organically. The book-to-bill ratio stood at 1.15, signaling robust future demand. Shares moved from around 685p to near 767p following the announcement. Full-year adjusted earnings are now tracking ahead of…

Read more 12
GLP-1 Weight Loss Drugs Linked to Hair Loss Risk, BMJ Study Finds July 24
📅 16 hours ago

GLP-1 Weight Loss Drugs Linked to Hair Loss Risk, BMJ Study Finds July 24

New BMJ study finds GLP-1 weight loss drugs like Ozempic and Mounjaro linked to 37-68% higher hair loss risk. Researchers say the absolute risk remains low and hair loss is typically reversible.

Read more 12
Volkswagen Profit Falls 33% as China Competition Intensifies
📅 17 hours ago

Volkswagen Profit Falls 33% as China Competition Intensifies

Volkswagen reported a sharp drop in earnings on July 24, 2026, as tougher competition in China continued to weigh on its business. The German automaker said profit fell 33%, driven by weaker vehicle sales, intense price competition, and growing pressure from local electric vehicle (EV) manufacturers. The latest results also led Volkswagen to lower its…

Read more 12
HSBC (LSE: HSBA) to Sell Singapore Insurance Unit for £1.6B, Signs 15-Year Allianz Partnership
📅 17 hours ago

HSBC (LSE: HSBA) to Sell Singapore Insurance Unit for £1.6B, Signs 15-Year Allianz Partnership

HSBC agreed to sell its Singapore life and health insurance business to Allianz on July 24, 2026. The deal values HSBC Life Singapore at S$2.7 billion, or roughly £1.6 billion. It will also enter a 15-year exclusive bancassurance partnership with the German insurer. The transaction generates a pre-tax gain of $1.8 billion and lifts HSBC’s…

Read more 12
Samsung Galaxy Z Fold 8 Launches at S$2,498 With Wider Screen Design
📅 18 hours ago

Samsung Galaxy Z Fold 8 Launches at S$2,498 With Wider Screen Design

Samsung launches Galaxy Z Fold 8 at S$2,498 in Singapore with new wide 4:3 aspect ratio screen. Prices up 20-48% globally due to memory chip shortage. Pre-orders open now, devices available August 10.

Read more 12
Intel Stock Surges 11% on Q2 Earnings Beat, AI Demand Lifts Revenue 25%
📅 19 hours ago

Intel Stock Surges 11% on Q2 Earnings Beat, AI Demand Lifts Revenue 25%

Intel reports Q2 revenue of $16.1B, up 25% YoY, beating estimates by $1.68B. AI data center revenue surges 59%. Stock jumps 11% after-hours. Meyka grades INTC a B with $124.19 quarterly forecast.

Read more 12
Intel Stock Rallies 4% on Q2 Earnings Beat, AI Demand Surge July 24
📅 19 hours ago

Intel Stock Rallies 4% on Q2 Earnings Beat, AI Demand Surge July 24

Intel shares jump 4% after Q2 earnings beat with $16.1B revenue, 25% growth, and upbeat Q3 guidance. AI demand for server CPUs drives fastest revenue growth since 2011.

Read more 12

RANK News FAQ